Economic valuation of recommendations
| Recommendation | Level of evidence and strength of recommendation for cost effectiveness |
|---|---|
| 1 | NA |
| 2 | 2c, B |
| 3 | 2b, B |
| 4 | 1b, 2b; B |
| 5 | 2c, B |
| 6 | 2c, B; 5, D |
| 7 | 2b, B |
| 8 | 2b, B |
| 9 | 2b, B |
| 10 | NA |
| 11 | NA |
| 12 | 2c, B |
| 13 | 2c, B |
| 14 | 1b, A (for being not cost effective*) |
| 15 | NA |
↵* Not cost effective on the group level assessed in the respective studies, but not necessarily on the level of the exceptional individual patient as suggested in the recommendation.
NA, not applicable.